Episode 86: The Metastatic Endometrial Cancer landscape with Dr Gemma Eminowicz (1/2)
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
-
Narrado por:
-
De:
Send us a text
Dr Gemma Eminowicz returns for 2026!!
Join us as we discuss the metastatic endometrial cancer landscape with Simply Oncology 'friend of the show' Dr Gemma Eminowicz from University College Hospital London.
Advanced endometrial cancer is so much more than carboplatin and paclitaxel. It now has the complete range of oncological treatments;
- Chemotherapy
- Immunotherapy
- Antibody Drug Conjugates
- Hormone therapy
- Targeted therapy
- Radiotherapy
We look at how the molecular testing in endometrial cancer has shaped advanced endometrial cancer therapy.
We look at the arrival of chemo-immunotherapy in the MMRd group and now in the MMRp patient group.
In the MMR proficient group we discuss the merits of 1st line Chemo-immunotherapy versus sequencing treatment to allow potential VEGF targeted therapy.
Gemma shares her invaluable experience and helps Mike understand advanced endometrial cancer.
Enjoy!!